NO20035146D0 - Granul¶re preparater av gaboksadol - Google Patents

Granul¶re preparater av gaboksadol

Info

Publication number
NO20035146D0
NO20035146D0 NO20035146A NO20035146A NO20035146D0 NO 20035146 D0 NO20035146 D0 NO 20035146D0 NO 20035146 A NO20035146 A NO 20035146A NO 20035146 A NO20035146 A NO 20035146A NO 20035146 D0 NO20035146 D0 NO 20035146D0
Authority
NO
Norway
Prior art keywords
gaboxadol
granular preparations
granular
preparations
Prior art date
Application number
NO20035146A
Other languages
English (en)
Other versions
NO20035146L (no
Inventor
Michiel Onne Elema
Lene Andresen
Per Holm
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20035146L publication Critical patent/NO20035146L/no
Publication of NO20035146D0 publication Critical patent/NO20035146D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20035146A 2001-05-21 2003-11-19 Granul¶re preparater av gaboksadol NO20035146D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100817 2001-05-21
PCT/DK2002/000332 WO2002094225A1 (en) 2001-05-21 2002-05-17 Granular preparations of gaboxadol

Publications (2)

Publication Number Publication Date
NO20035146L NO20035146L (no) 2003-11-19
NO20035146D0 true NO20035146D0 (no) 2003-11-19

Family

ID=8160520

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035146A NO20035146D0 (no) 2001-05-21 2003-11-19 Granul¶re preparater av gaboksadol

Country Status (26)

Country Link
US (1) US20040157876A1 (no)
EP (1) EP1389091A1 (no)
JP (1) JP2004530695A (no)
KR (1) KR20030097890A (no)
CN (1) CN1511026A (no)
AR (1) AR033896A1 (no)
AU (1) AU2002338855B2 (no)
BG (1) BG108441A (no)
BR (1) BR0209834A (no)
CA (1) CA2447603A1 (no)
CZ (1) CZ20033269A3 (no)
EA (2) EA200700703A1 (no)
HR (1) HRP20030950A2 (no)
HU (1) HUP0400051A2 (no)
IL (1) IL158733A0 (no)
IS (1) IS7020A (no)
ME (1) MEP6308A (no)
MX (1) MXPA03010596A (no)
NO (1) NO20035146D0 (no)
NZ (1) NZ547636A (no)
PL (1) PL366541A1 (no)
SK (1) SK15542003A3 (no)
UA (1) UA80092C2 (no)
WO (1) WO2002094225A1 (no)
YU (1) YU92103A (no)
ZA (1) ZA200308594B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2385749A1 (en) * 1999-09-28 2001-04-05 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
PL1641456T3 (pl) 2003-06-25 2010-08-31 H Lundbeck As Gaboksadol do leczenia depresji i innych zaburzeń afektywnych
TW200528098A (en) * 2003-12-18 2005-09-01 Lundbeck & Co As H Treatment of insomnia in human patients
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP2292222A1 (en) 2005-01-28 2011-03-09 H. Lundbeck A/S Polymorphic Forms of a GABAA Agonist
EP1906953A4 (en) * 2005-04-29 2009-05-20 Lundbeck & Co As H FORMS OF ACID SALTS AND BASIC SALTS OF GABOXADOL
JP5792061B2 (ja) * 2008-05-30 2015-10-07 サイコジェニックス・インコーポレーテッドＰｓｙｃｈｏｇｅｎｉｃｓ Ｉｎｃ． 神経及び精神障害の治療法
CA2732636A1 (en) * 2008-09-01 2009-05-07 H. Lundbeck A/S Pharmaceutical composition comprising gaboxadol and an inhibitor of pat1 or oat
WO2013090452A1 (en) 2011-12-12 2013-06-20 Orbis Biosciences, Inc. Sustained release particle formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315934A (en) * 1979-09-24 1982-02-16 Sandoz Ltd. Organic compounds
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
CA2385749A1 (en) * 1999-09-28 2001-04-05 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
WO2002094225A1 (en) 2002-11-28
NZ547636A (en) 2008-03-28
AR033896A1 (es) 2004-01-07
EA200301282A1 (ru) 2004-04-29
IL158733A0 (en) 2004-05-12
CA2447603A1 (en) 2002-11-28
BG108441A (en) 2005-02-28
AU2002338855B2 (en) 2007-08-16
UA80092C2 (en) 2007-08-27
PL366541A1 (en) 2005-02-07
NO20035146L (no) 2003-11-19
SK15542003A3 (sk) 2004-05-04
HUP0400051A2 (hu) 2004-04-28
CZ20033269A3 (en) 2004-03-17
US20040157876A1 (en) 2004-08-12
KR20030097890A (ko) 2003-12-31
EA009731B1 (ru) 2008-02-28
JP2004530695A (ja) 2004-10-07
CN1511026A (zh) 2004-07-07
HRP20030950A2 (en) 2005-08-31
BR0209834A (pt) 2004-06-15
EP1389091A1 (en) 2004-02-18
EA200700703A1 (ru) 2007-08-31
MEP6308A (xx) 2010-02-10
IS7020A (is) 2003-11-10
MXPA03010596A (es) 2004-03-09
ZA200308594B (en) 2004-11-04
YU92103A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20035087D0 (no) Anvendelse av HMG fragment som anti-inflammatoriske midler
DK1326864T3 (da) Sammenföjede aryl- eller heteroarylforbindelser som antiinflammatoriske og analgetiske midler
NO20050136D0 (no) Fremgangsmate for fremstilling av mikropartikler
NO20035193L (no) Nye pyrrolderivater som farmas degree ytiske midler
NO20034439D0 (no) Benzamidinderivater
ATE319451T1 (de) Tetrahydrochinolin-derivate
NO20033203D0 (no) Terapeutiske heterocykliske forbindelser
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
NO20044916L (no) Preparater av sulfinylacetamid
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
NO20011360L (no) Granul¶rt produkt
NO20033205D0 (no) Terapeutiske kromanforbindelser
ATE459598T1 (de) Sulfonamidderivate
NO20013507L (no) Blandinger for behandling av inflammatoriske reaksjoner
EE200300447A (et) Asendatud bensofuraan-2-karboksamiidide derivaadid
NO20035146D0 (no) Granul¶re preparater av gaboksadol
DE50209070D1 (de) Sämaschine
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20041968L (no) Anvendelse av cystationin
DE60223468D1 (de) Gel-ummanteltes Saatgut
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
FR2824092B1 (fr) Ensemble d'elements de construction
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
DE60212694D1 (de) Benzothiazolderivaten

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application